News round-up by DDW’s Megan Thomas for 25-29 October
DDW’s Megan Thomas has selected five stories which highlight the results that can be achieved through collaboration in the drug discovery sector.
A team of University of Queensland researchers have identified a pathway helping the breast cancer protein BRCA1 repair damaged DNA in a study that will inform future targeted therapies.
Culture Biosciences has selected Scispot.io to digitise and automate its media preparation workflows while maintaining an audit trail.
Ferrer and Treeway have entered into a licence agreement for the development and commercialisation of an oral formulation of edaravone (TW001/FNP122) for Amyotrophic Lateral Sclerosis (ALS) in certain territories, including Europe and some Asian countries.
Researchers from the University of Dundee and Promega Corporation have shown how a “three-headed hydra” significantly improves efficacy in targeted protein degradation.
Waters Corporation and Sartorius have partnered to provide bioprocess experts with direct access to high-quality mass spectrometry (MS) data to accelerate the speed and improve the accuracy of biopharmaceutical process development.